GURNARI, CARMELO
 Distribuzione geografica
Continente #
NA - Nord America 7.734
AS - Asia 4.356
EU - Europa 2.669
Continente sconosciuto - Info sul continente non disponibili 737
SA - Sud America 694
AF - Africa 65
OC - Oceania 7
Totale 16.262
Nazione #
US - Stati Uniti d'America 7.527
SG - Singapore 2.148
IT - Italia 1.167
HK - Hong Kong 549
BR - Brasile 548
RU - Federazione Russa 452
CN - Cina 437
BD - Bangladesh 323
VN - Vietnam 307
JP - Giappone 192
GB - Regno Unito 182
FI - Finlandia 173
DE - Germania 148
IE - Irlanda 122
CA - Canada 100
FR - Francia 96
NL - Olanda 91
KR - Corea 85
IN - India 75
ID - Indonesia 71
AT - Austria 58
MX - Messico 52
AR - Argentina 49
SE - Svezia 37
ES - Italia 29
PL - Polonia 29
EC - Ecuador 24
TR - Turchia 22
CO - Colombia 20
ZA - Sudafrica 19
IQ - Iraq 17
IR - Iran 16
PY - Paraguay 16
JM - Giamaica 14
UA - Ucraina 14
MA - Marocco 13
VE - Venezuela 13
PH - Filippine 11
AE - Emirati Arabi Uniti 10
JO - Giordania 10
PK - Pakistan 9
UZ - Uzbekistan 9
CL - Cile 8
CZ - Repubblica Ceca 8
MY - Malesia 8
DZ - Algeria 7
AL - Albania 6
AU - Australia 6
BE - Belgio 6
IL - Israele 6
NG - Nigeria 6
RO - Romania 6
SA - Arabia Saudita 6
SV - El Salvador 6
BB - Barbados 5
BO - Bolivia 5
BY - Bielorussia 5
CR - Costa Rica 5
EG - Egitto 5
GR - Grecia 5
GT - Guatemala 5
KZ - Kazakistan 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
PT - Portogallo 5
TH - Thailandia 5
UY - Uruguay 5
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
EE - Estonia 4
HN - Honduras 4
HR - Croazia 4
NI - Nicaragua 4
BG - Bulgaria 3
ET - Etiopia 3
KE - Kenya 3
KG - Kirghizistan 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
TN - Tunisia 3
TT - Trinidad e Tobago 3
TW - Taiwan 3
AM - Armenia 2
DK - Danimarca 2
EU - Europa 2
KW - Kuwait 2
LU - Lussemburgo 2
MD - Moldavia 2
OM - Oman 2
PR - Porto Rico 2
QA - Qatar 2
RS - Serbia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BH - Bahrain 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
CG - Congo 1
CM - Camerun 1
CY - Cipro 1
Totale 15.514
Città #
Singapore 896
San Jose 747
Wilmington 658
Houston 612
Ashburn 580
Hong Kong 543
Council Bluffs 379
Rome 312
New York 185
Los Angeles 183
Creede 182
Tokyo 182
Santa Clara 175
Beijing 159
Helsinki 132
Woodbridge 128
The Dalles 122
Fairfield 121
Dallas 112
Dublin 112
Chandler 100
Ho Chi Minh City 100
Milan 94
Buffalo 93
Moscow 79
Hanoi 66
Center 63
Seattle 63
Chicago 60
Denver 57
São Paulo 53
Jakarta 51
London 44
Medford 42
Nuremberg 42
Atlanta 41
Naples 40
Phoenix 40
Cambridge 38
North Bergen 35
Lauterbourg 34
Munich 30
Ann Arbor 29
Lappeenranta 29
Mexico City 28
Redondo Beach 27
Brooklyn 26
Orem 25
Toronto 25
Montreal 23
Vienna 23
Boardman 21
Frankfurt am Main 21
Lawrence 20
Stockholm 20
Turin 20
Warsaw 20
Rio de Janeiro 19
Miami 18
Palermo 18
Amsterdam 17
Bari 17
Brasília 17
Washington 17
Dearborn 16
Hackensack 16
Las Vegas 16
Salt Lake City 16
Bologna 15
Haiphong 15
Elk Grove Village 14
Parma 14
Baghdad 13
Johannesburg 13
Philadelphia 13
San Diego 13
Belo Horizonte 12
Chennai 12
Da Nang 12
Seoul 12
Boston 11
Kilburn 11
Pune 11
Amman 10
Columbus 10
Guangzhou 10
Guayaquil 10
Manchester 10
Menlo Park 10
Milwaukee 10
Monte Vista 10
Poplar 10
Queens 10
Shanghai 10
Charlotte 9
Curitiba 9
Engelhard 9
Jacksonville 9
Kingston 9
Monte Porzio Catone 9
Totale 8.684
Nome #
Identification of i(X)(p10) as the sole molecular abnormality in atypical chronic myeloid leukemia evolved into acute myeloid leukemia 510
Acute promyelocytic leukemia (APL) in very old patients: real-life behind protocols 365
Early detection of IgH monoclonal rearrangenent in follicular spicules of the nose preceding multiple myeloma diagnosis. Case report and review of the literature 354
The emerging role of measurable residual disease detection in AML in morphologic remission 339
Erythropoietin levels and erythroid differentiation parameters in patients with lower-risk myelodysplastic syndromes 324
Immunologia dei trapianti e trapianto di cellule staminali ematopoietiche 287
The Role of Forkhead Box Proteins in Acute Myeloid Leukemia 261
ACUTE LEUKEMIA AND LATENT TUBERCULOSIS INFECTION IN ITALY: QUANTIFERON-TB TEST SCREENING IN A LOW TUBERCULOSIS INCIDENCE COUNTRY 239
Deciphering treatment patterns in non-severe/moderate aplastic anemia: an international observational study 237
WT1 evaluation in higher-risk myelodysplastic syndrome patients treated with azacitidine 227
Clonal hematopoiesis–derived therapy-related myeloid neoplasms after autologous hematopoietic stem cell transplant for lymphoid and non-lymphoid disorders 220
Genetic analysis of erythrocytosis reveals possible causative and modifier gene mutations 211
Applications and efficiency of flow cytometry for leukemia diagnostics 202
From bench to bedside and beyond: Therapeutic scenario in acute myeloid leukemia 187
Vitamin C Deficiency in Patients With Acute Myeloid Leukemia 173
Applicability of 2022 classifications of acute myeloid leukemia in the real-world setting 173
Expression profiling of extramedullary acute myeloid leukemia suggests involvement of epithelial-mesenchymal transition pathways 157
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia 153
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters 153
A complex clinical presentation of ultra-high risk acute promyelocytic leukemia: A case report and insights on management 149
Use of Primary Prophylaxis with G-CSF in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy Does Not Affect Quality of Response 147
Culprit or innocent bystander? The case of a new fast-moving hemoglobin J variant in a pregnant woman 145
Terminal deoxynucleotidyl transferase (TdT) expression is associated with FLT3-ITD mutations in Acute Myeloid Leukemia 141
Germline DDX41 mutations define a unique subtype of myeloid neoplasms 139
Acute Promyelocytic Leukemia in Children: A Model of Precision Medicine and Chemotherapy-Free Therapy 134
Allogeneic haematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for lymphoma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 128
From Clonal Hematopoiesis to Therapy-Related Myeloid Neoplasms: The Silent Way of Cancer Progression 125
The Anti-Leukemia Effect of Ascorbic Acid: From the Pro-Oxidant Potential to the Epigenetic Role in Acute Myeloid Leukemia 122
A non-cytotoxic regimen of decitabine to treat refractory T-cell large granular lymphocytic leukemia 121
A Focus on Intermediate-Risk Acute Myeloid Leukemia: Sub-Classification Updates and Therapeutic Challenges 120
A Comprehensive Review of the Genomics of Multiple Myeloma: Evolutionary Trajectories, Gene Expression Profiling, and Emerging Therapeutics 118
Donor selection for allogeneic hematopoietic cell transplant in a patient with JAK2 V617F primary myelofibrosis and SH2B3/LNK germline variant 115
A fatal case of peritonitis due to colonic localization of acute myeloid leukemia 115
Diagnostic capabilities, clinical features, and longitudinal UBA1 clonal dynamics of a nationwide VEXAS cohort 113
Essential Thrombocythemia and Acquired von Willebrand Syndrome: The Shadowlands between Thrombosis and Bleeding 113
Machine learning integrates genomic signatures for subclassification beyond primary and secondary acute myeloid leukemia 112
Leukemia cutis in a patient with acute myeloid leukemia undergoing Azacitidine-Venetoclax: case presentation and review of the literature 111
Germline DDX41 mutations cause ineffective hematopoiesis and myelodysplasia 110
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World Experience 110
Large Granular Lymphocytic Leukemia: From Immunopathogenesis to Treatment of Refractory Disease 109
'We cannot paint them all with the same brush': the need for a better definition of patients with myelodysplastic syndromes for clinical trial design 108
Comprehensive transcriptomic analysis of VISTA in acute myeloid leukemia: insights into its prognostic value 107
When Poisons Cure: The Case of Arsenic in Acute Promyelocytic Leukemia 107
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AML 107
Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M 106
Myelodysplastic syndromes with del(5q): A real-life study of determinants of long-term outcomes and response to lenalidomide 105
Response Rates and Transplantation Impact in Patients with Relapsed Acute Promyelocytic Leukemia 104
Overlapping features of hepatic complications after hematopoietic cell transplantation in a rare t-cell lymphoma: a clinical challenge 101
Acute Promyelocytic Leukemia: Long-Term Outcomes from the HARMONY Project 101
Molecular characterization of the histone acetyltransferase CREBBP/EP300 genes in myeloid neoplasia 99
Landscape of biallelic DNMT3A mutant myeloid neoplasms 99
Evolution of transcriptomic profiles in relapsed inv(16) acute myeloid leukemia 99
LGL Clonal Expansion and Unexplained Cytopenia: Two Clues Don't Make an Evidence 98
Have we reached a molecular era in myelodysplastic syndromes? 98
What are the considerations for the pharmacotherapeutic management of acute promyelocytic leukemia in children? 98
UBA1 Screening in Sweet Syndrome With Hematological Neoplasms Reveals a Novel Association Between VEXAS and Chronic Myelomonocytic Leukemia 96
Allogeneic hematopoietic cell transplantation for therapy-related myeloid neoplasms arising following treatment for multiple myeloma: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT 95
Characteristics and outcome of acute myeloid leukemia with uncommon retinoic acid receptor-alpha (RARA) fusion variants 94
The Interactome between Metabolism and Gene Mutations in Myeloid Malignancies 94
Hepatitis C Infection Associated with Acquired Pure Red Cell Aplasia 92
Aplastic anemia: quo vadis? 90
Update on VEXAS and role of allogeneic bone marrow transplant: Considerations on behalf of the Chronic Malignancies Working Party of the EBMT 89
A study of Telomerase Reverse Transcriptase rare variants in myeloid neoplasia 88
Recent Advances in Adult Post-Transplant Lymphoproliferative Disorder 88
Allogeneic haematopoietic cell transplantation for advanced systemic mastocytosis: Best practice recommendations on behalf of the EBMT Practice Harmonisation and Guidelines Committee 88
Vacuolization of hematopoietic precursors: an enigma with multiple etiologies 88
Clonal trajectories and cellular dynamics of myeloid neoplasms with SF3B1 mutations 88
Arsenic trioxide and all-trans retinoic acid treatment for childhood acute promyelocytic leukaemia 88
The combination of bortezomib with chemotherapy to treat relapsed/refractory acute lymphoblastic leukaemia of childhood 87
Impact of Time to Treatment Initiation on Quality of Response in Patients with Acute Myeloid Leukemia Receiving Intensive Chemotherapy 86
Rare germline alterations of myeloperoxidase predispose to myeloid neoplasms 84
Personalized risk schemes and machine learning to empower genomic prognostication models in myelodysplastic syndromes 82
Significance of hereditary gene alterations for the pathogenesis of adult bone marrow failure versus myeloid neoplasia 82
Advances in the pathogenesis of FLT3 -mutated acute myeloid leukemia and targeted treatments 82
Clinical and molecular determinants of clonal evolution in aplastic anemia and paroxysmal nocturnal hemoglobinuria 82
Molecular landscape of immune pressure and escape in aplastic anemia 82
Allogeneic hematopoietic cell transplantation for VEXAS syndrome: results of a multicenter study of the EBMT 82
Non canonical c-CBL mutations define a specific phenotype of myeloid neoplasia 82
Copper Deficiency 81
Development and Validation of a Prediction Model of Outcome after B-Cell Maturation Antigen-Directed Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Multiple Myeloma 81
Individual HLA heterogeneity and its implications for cellular immune evasion in cancer and beyond 81
Recruitment of MLL1 complex is essential for SETBP1 to induce myeloid transformation 80
Allogenic haematopoietic stem cell transplantation in VEXAS: A review of 33 patients 80
Targeting apoptosis dysregulation in myeloid malignancies - The promise of a therapeutic revolution 80
Incidence and Characteristics of Perianal Infections in CPX-351-Treated AML Patients 79
Clinical and basic implications of dynamic T cell receptor clonotyping in hematopoietic cell transplantation 78
A tower of babel of acronyms? The shadowlands of MGUS/MBL/CHIP/TCUS 78
Does IPSS-R downstaging before transplantation improve the prognosis of patients with myelodysplastic neoplasms? 78
Single-cell characterization of leukemic and non-leukemic immune repertoires in CD8+ T-cell large granular lymphocytic leukemia 78
Navigating ‘grey areas’ and challenges during evaluation of transplant eligibility in specific myelofibrosis populations: a perspective on behalf of the Chronic Malignancies Working Party of the EBMT 75
Clonal hematopoiesis in large granular lymphocytic leukemia 75
STAT5b-RARa-positive acute myeloid leukemia: Diagnostic and therapeutic challenges of a rare AML subtype 74
A multimodal analysis of genomic and RNA splicing features in myeloid malignancies 74
Molecular Targeted Therapy in Myelodysplastic Syndromes: New Options for Tailored Treatments 74
Monoclonal IgM gammopathy in adult acquired pure red cell aplasia: culprit or innocent bystander? 73
T-cell large granular lymphocytic leukemia associated with inclusion body myositis 73
Circulating microbial content in myeloid malignancy patients is associated with disease subtypes and patient outcomes 72
Functional characterization and response to FLT3 inhibitors in acute myeloid leukaemia with a non-canonical FLT3 mutation: A proof of concept 72
Deciphering the Therapeutic Resistance in Acute Myeloid Leukemia 72
New approaches to idiopathic neutropenia in the era of clonal hematopoiesis 71
Totale 12.594
Categoria #
all - tutte 71.792
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 71.792


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022173 0 0 0 5 1 35 9 13 12 14 18 66
2022/20231.161 28 23 13 52 22 62 768 40 33 16 44 60
2023/2024670 91 37 51 45 67 121 70 47 35 36 12 58
2024/20253.647 52 489 248 162 49 162 252 372 453 378 566 464
2025/20266.420 455 377 661 485 459 254 800 753 761 480 577 358
2026/20272.328 416 287 1.105 520 0 0 0 0 0 0 0 0
Totale 16.262